location: Current position: Home >> Scientific Research >> Paper Publications

DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo

Hits:

Affiliation of Author(s):药学院

Journal:J Pharmacy Pharmacology

All the Authors:liuxinyong

First Author:guoxiuli

Indexed by:Unit Twenty Basic Research

Document Code:lw-158882

Volume:66

Issue:3

Page Number:398

Translation or Not:no

Date of Publication:2014-03-01

Pre One:Combination treatment of Ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer

Next One:Heterocycle-thioacetic Acid Motif: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activities